Stay updated on Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record is now displayed with its trial overview, eligibility criteria, treatment plan, outcome measures, record dates, and study documents, replacing an access-denied message.
    Difference
    98%
    Check dated 2026-11-08T13:17:59.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.2 to v3.8.0; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:09:00.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition notice stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:28:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:06:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T14:06:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    - The NCT02730546 study page now shows a 403 Forbidden page, replacing the previous study details. This prevents viewing the trial's overview, eligibility criteria, locations, and contacts.
    Difference
    25%
    Check dated 2026-09-20T20:36:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo+Radiation Pre-Surgery in Gastric Cancer Clinical Trial page.